United States · Bill · HR
H.R. 4983 (114th)
To provide information to prescribers in Federally qualified health centers and facilities of the Indian Health Service on best practices for prescribing naloxone.
Introduced
18 April 2016
Last action
—
Status
Referred to the Subcommittee on Indian, Insular and Alaska Native Affairs.
Sponsors
—
Subjects
Discovery layer
Source updated
7 April 2025
Summary
This bill requires the Department of Health and Human Services to provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing naloxone (a prescription drug used to rapidly reverse an opioid overdose) for patients a provider identifies as having an elevated risk of opioid overdose. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 18 April 2016
Introduced in House (PDF)
Introduced in House · EN · 18 April 2016
Introduced in House
summary · EN · 18 April 2016
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/114th-congress/house-bill/4983
- Open data entity: https://api.congress.gov/v3/bill/114/hr/4983